CT-127 – phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi) - Hyman, D; Kummar, S; Farago, A (Proceedings of the 10th Annual Meeting of the American Association for Cancer Research; 2019, 2019)
et al.